Saturday, 3 November 2012
Pradaxa bleeding risk appears no worse than warfarin - FDA
(Reuters) - The risk of serious bleeding among new users of Pradaxa, a blood-clot preventer made by Germany's Boehringer Ingelheim, appeared to be no higher than in patients on the widely used standard blood thinner warfarin, U.S. regulators said.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment